только для медицинских специалистов
Консультант врача. Электронная медицинская библиотека

Консультант врача

Электронная медицинская библиотека

Доступ к библиотеке Версия для слабовидящих
Раздел 4 / 10
Страница 1 / 1

Список литературы

  1. Munro MG. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017 Apr;40:3-22.
  2. National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management NICE guideline [NG88]. 2018. Available from: https://www.nice.org.uk/guidance/ng88. Accessed 25 Feb 2020.
  3. Munro MG, Critchley HO, Broder MS, et al. The FIGO classification system (“PALM- COEIN”) for causes of abnormal uterine bleeding in non-gravid women in the reproductive years, including guidelines for clinical investigation. Int J Gynaecol Obstet 2011.
  4. Munro MG, Critchley HOD, Fraser IS., FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions.
  5. National Collaborating Centre for Women’s and Children’s Health, National Institute for Health and Clinical Excellence. Clinical guideline CG44: heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists.
  6. Singh S, Best C, Dunn S, Leyland N, Wolfman WL. No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can. 2018 May;40(5):e391-e415.
  7. Damsa C, Bumb A, Bianchi-Demicheli F, et al. “Dopamine-dependent” side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry 2004;65:1064–8.
  8. Thangavelu K, Geetanjali S. Menstrual disturbance and galactorrhea in people taking conventional antipsychotic medications. Exp Clin Psychopharmacol 2006;144:459–60.
  9. Kelly DL, Conley RR. Sexuality and schizophrenia: a review. Schizophr Bull 2004;767– 79.
  10. Kabalak AA, Soyal OB, Urfalioglu A, et al. Menometrorrhagia and tachyarrhythmia after using oral and topical ginseng. J Womens Health (Larchmt) 2004;13:830–3, 1071.
  11. ACOG committee opinion no. 557: Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013 Apr;121(4):891-896.
  12. Toth M, Patton DL, Esquenazi B, Shevchuk M, Thaler H, Divon M. Association between Chlamydia trachomatis and abnormal uterine bleeding. Am J Reprod Immunol. 2007 May;57(5):361-6.
  13. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016 Jul;34:54-65.
  14. Unim B. et al. Role of pap-test in cervical cancer prevention: a systematic review and meta-analysisBrigid Unim //European Journal of Public Health. – 2014. – Т. 24.
  15. Kouides PA, Conard J, Peyvandi F, et al. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005;84:1345–51.
  16. Grimbizis GF, Tsolakidis D, Mikos T. A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology. Fertil Steril. 2010 Dec;94(7):2720-5.
  17. Kaveh M, Sadegi K, Salarzaei M, Parooei F. Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography, and hysteroscopy in evaluating the endometrial polyps in women with abnormal uterine bleeding: a systematic review .
  18. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril 2018;109:389-97.
  19. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy. Fertil Steril. 2001 Aug;76(2):350-7.
  20. Narice BF, Delaney B, Dickson JM. Endometrial sampling in low-risk patients with abnormal uterine bleeding: a systematic review and meta-synthesis. BMC Fam Pract 2018 30;19:135.
  21. Lukes A. S. et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial //Obstetrics & Gynecology. – 2010. – Т. 116. – №. 4. – С. 865-875. [Internet].
  22. Lethaby A, Duckitt K, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013;1:CD000400.
  23. Douglass LA, Davis AM. Assessment and Management of Heavy Menstrual Bleeding. JAMA. 2020 Jan 21;323(3):270-271.
  24. Gupta J, Kai J, Middleton L, et al. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 2013;368:128–37.
  25. Munro MG, Mainor N, Basu R, et al. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol 2006;108:924–9.
  26. Fraser I. S. et al. Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest. The European Journal of Contraception & Reproductive Health Care. – 2011. – Т. 16. – №. 4. – С. 258-269.;
  27. Sweet M. G. et al. Evaluation and management of abnormal uterine bleeding in premenopausal women //American family physician. – 2012. – Т. 85. – №. 1. – С. 35-43.
  28. Laufer M. R., Rein M. S. Treatment of abnormal uterine bleeding with gonadotropin- releasing hormone analogues //Clinical obstetrics and gynecology. – 1993. – Т. 36. – №. 3. – С. 668-678.
  29. Fergusson RJ, Lethaby A, Shepperd S, et al. . Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2013;CD000329.
  30. Серов В. Н. и др. Гинекология: руководство для врачей/под ред //ВН Серова, ЕФ Кира. М.: Литтерра. – 2008. Литтерра. Москва;
  31. Приказ Минздрава России от 13.03.2019 N 124н “Об утверждении порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения” (Зарегистрировано в Минюсте России 24.04.2019 N 54495).
  32. Mullins, T.L. Evaluation and management of adolescents with abnormal uterine bleeding / T.L. Mullins, R.J. Miller, E.S. Mullins // Pediatr Ann. – 2015. – vol.44. – N 9. – P. 218-222.
  33. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign / ACOG Committee Opinion No. 651 American College of Obstetricians and Gynecologists // Obstet Gynecol. – 2015. – vol.126. – P. 143-146.
  34. Deligeoroglou, E. Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology / E. Deligeoroglou, V. Karountzos, G. Creatsas // Gynecol Endocrinol. – 2013. – vol.29. – N 1. – P. 74-78.
  35. Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol. 2010;116(4):865–875.
  36. Thorne, J.G. Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception [commentary]? / J.G. Thorne, P.D. James, R.L. Reid // Contraception. – 2018. – vol.98. – P. 1–3.
  37. Lumsden, M.A. Tranexamic acid therapy for heavy menstrual bleeding / M.A. Lumsden, L. Wedisinghe // Expert Opin Pharmacother. – 2011. – vol.12. – N 13. – P. 2089-2095.
  38. An Open-Label, Single-Arm, Efficacy Study of Tranexamic Acid in Adolescents with Heavy Menstrual Bleeding / S.H. O’Brien [et al.] //J Pediatr Adolesc Gynecol. – 2019. – vol.32. – N 3. – P. 305-311.
  39. Bryant-Smith, A.C. Antifibrinolytics for heavy menstrual bleeding / A.C. Bryant-Smith, A. Lethaby, C. Farquhar, M. Hickey // Cochrane Database Syst Rev. – 2018. – Issue 4.
  40. The Royal Children’s Hospital, Melbourne, Australia, Clinical Practice Guideline on Adolescent gynaecology - Heavy menstrual bleeding [Internet, last updated August 2020.
  41. Naoulou, B. Efficacy of tranexamic acid in the treatment of idiopathic and non- functional heavy menstrual bleeding: a systematic review // B. Naoulou, M.C. Tsai // Acta Obstet Gynecol Scand. – 2012. – vol.91. – N 5. – P. 529-537.
  42. DeSilva N.K. Abnormal uterine bleeding in the adolescent patient / N.K. DeSilva // The Female Patient. – 2010. – vol. 35. – P. 25-28.
  43. Kiran Panesar et al. Managing Menorrhagia. US Pharm. 2011;36(9):56- https://www.uspharmacist.com/article/managing-menorrhagia.
  44. Primary care management of abnormal uterine bleeding // K.E. Hartmann [et al/] // Comparative effectiveness review No.96. AHRQ. Agency for healthcareresearch and quality. – 2013.
  45. Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Committee Opinion No. 557. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013.
  46. Non-surgical management of heavy menstrual bleeding: a systematic review / K.A. Matteson [et al.] // Ostet Gynecol. 2013. – vol.121. – N 3. – P. 632-643.
  47. Adams Hillard, P. J. Menstruation in Adolescents / P.J. Adams Hillard // Annals of the New York Academy of Sciences. – 2008. – 1135. – P. 29-35.
  48. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785. Obstet Gynecol. 2019 Sep;134(3):e71-e83.
  49. Heavy menstrual bleeding: assessment and management NICE guideline [NG88] Published date: 14 March 2018 Last updated: 31 March 2020.
  50. De Silva N 2019, Abnormal uterine bleeding in adolescents: Management [Internet]. UpToDate. Available from: https://www.uptodate.com/contents/abnormal-uterine-bleeding- in-adolescents-management.
  51. Н.М. Веселова, Е.В. Уварова // Патент на изобретение RU 2327462 C1 «Способ лечения маточных кровотечений пубертатного периода».
  52. Heikinheimo, O. The current status of hormonal therapies for heavy menstrual bleeding // Best Pract Res Clin Obstet Gynaecol. – 2017. – vol.40. – P. 111-120.
  53. Oral tranexamic acid versus combined oral contraceptives for adolescent heavy menstrual bleeding: a pilot study / L.V. Srivaths [et al.] // J Pediatr Adolesc Gynecol. – 2015. – vol.28. – N 4. – P. 254-257.
  54. Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding. ACOG Committee Opinion No. 785 / American College of Obstetricians and Gynecologists // Obstet. Gynecol. – 2019. – vol.134. – P. 71-83.
  55. lmaoğulları S., Aycan Z. Abnormal uterine bleeding in adolescents //Journal of clinical research in pediatric endocrinology. – 2018. – Т. 10. – №. 3.
  56. Combined hormonal contraceptives for heavy menstrual bleeding / A. Lethaby [et al.] // Cochrane Database Sys Rev. – 2019. – Issue 2.
  57. Hickey M, Higham JM, Fraser I. Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation. Cochrane Database Syst Rev. 2012;9:CD001895.
  58. Karakus, S. Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial / S. Karakus, G. Kiran, H. Ciralik // Aust N Z J Obstet Gynaecol. – 2009.
  59. Kakarla, N. The use of micronized progesterone for dysfunctional uterine bleeding in adolescent females / N. Kakarla, H.B. Boswell, R.K. Zurawin // Journal of pediatric &adolescent gynecology. – 2006. – vol.19. – N 2. – P. 151-152.
  60. Munro M.G.; Southern California Permanente Medical Group’s Abnormal Uterine Bleeding Working Group. Investigation of women with postmenopausal uterine bleeding: clinical practice recommendations. Perm. J. 2014; 18(1): 55-70.
  61. Astrup K, Olivarius N de F. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynecol Scand 2004;83:203–7.
  62. Bradshaw KD, Trait D. Postmenopausal bleeding. In: Marshburn PB, Hurst BS (Eds.) Disorders of Menstruation. Chicester, West Sussex, UK: Wiley-Blackwell, 2011;29: 2247-52.
  63. Baber R. J., Panay N., Fenton A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy // Climacteric. 2016. № 2 (19). C. 126–127.
  64. Prospective temporal validation of mathematical models to calculate risk of endometrial malignancy in patients with postmenopausal bleeding. Sladkevicius P, Opolskiene G, Valentin L Ultrasound Obstet Gynecol. 2017;49(5):649.
  65. Comparison of saline infusion sonography (SIS) versus SIS-guided endometrial sampling in the diagnosis of endometrial pathology. Moschos E, Bailey AA, Twickler DM J Clin Ultrasound. 2016;44(7):416. Epub 2016 Apr 18.
  66. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Dijkhuizen FP, Mol BW, Brölmann HA, Heintz AP Cancer. 2000;89(8):1765.
  67. Management of endometrial precancers. Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter Obstet Gynecol. 2012;120(5):1160. GL, Society of Gynecologic Oncology Clinical Practice Committee.
  68. Variation in endometrial thickening in women with amenorrhea on tamoxifen. Chang J, Powles TJ, Ashley SE, Iveson T, Gregory RK, Dowsett M Breast Cancer Res Treat. 1998;48(1):81.
  69. Association of tamoxifen and uterine sarcoma. Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD J Clin Oncol. 2002;20(11):2758.
  70. Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients. Cohen I, Altaras MM, Shapira J, Tepper R, Rosen DJ, Cordoba M, Zalel Y, Figer A, Yigael D, Beyth Y Int J Gynecol Pathol. 1996;15(2):
  71. Steven R Goldstein, MD Jamie N Bakkum-Gamez, MD Abnormal uterine bleeding and uterine pathology in patients on tamoxifen therapy All topics are updated as new evidence becomes available and our peer review process is complete. Literature review current th.
  72. Sadro CT. Imagine the Endometrium: A Pictorial Essay. Can Assoc Radiol J. 2016; 67 (3): 254-262.
  73. Society and College of Radiographes and British CB. Et al. Evaluation of the woman with postmenopausal bleeding: Society of Radiologist in Ultrasound-Sponsored Consensuns Conference statement. J Ultrasound Med. 2001; 20 (10):1025-1036.
  74. Clinical management of vaginal bleeding in postmenopausal women J. Carugno Obstetrics, Gynecology and Reproductive Sciences Department, Minimally Invasive Gynecology Unit, Miller School of Medicine, University of Miami, Miami, FL, USA.
  75. Sathiyathasan S ., Kannapar J. Unscheduled bleeding on HRT- do we always need to investigate for endometrial pathology? Int.J. Report Contracept.Obstet. Gyn.2017.6(10).4174.
  76. Chien PFW.,Voit D.,Clark TJ. Ultraconographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gyn Scand. In press.2002.
  77. Dave F.G., Laaiyemo R, Adedipi T. Unscheduled bleeding with hormone replacement therapy/ Obstet Gyn.2019;21(2): 95-101.
  78. Colombo N, Creutsberg C, Amant F, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol.2016;27(1):16-41.

Для продолжения работы требуется вход / регистрация